MEDI CAPS LTD. (MEDICAPQ) financials
MEDI CAPS LTD. (MEDICAPQ) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.
Incorporated in 1983, Medi-Caps Ltd is in the business of real estate and pharmaceuticals[1]
- Market Cap: ₹27.5Cr.
- Current Price: ₹22.0
- ROE: -0.93%
- ROCE: -0.91%
- Book Value: ₹53.4
- Dividend Yield: 0.00%
- 52W High / Low: ₹38.8/20.3
In Sep 2026, MEDI CAPS LTD. (MEDICAPQ) reported sales ₹0.12 Cr and net profit ₹-0.53 Cr.
Annual TTM: sales ₹1.52 Cr, net profit ₹-1.14 Cr.
Shareholding: Promoters 51.44% (Sep 2026), DIIs 0.02% (Sep 2026), Public 48.53% (Sep 2026), No. of Shareholders 10,369% (Sep 2026).
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 0.26 | 0.89 | 0.00 | 1.00 | 0.77 | 0.53 | 0.10 | 0.12 |
| YoY Sales growth | -91.48% | -54.82% | -100.00% | +2.04% | +196.15% | -40.45% | — | -88.00% |
| Expenses | 0.57 | 0.68 | 0.67 | 0.68 | 0.59 | 0.87 | 0.64 | 0.61 |
| Operating Profit | -0.31 | 0.21 | -0.67 | 0.32 | 0.18 | -0.34 | -0.54 | -0.49 |
| OPM % | -119.23% | 23.60% | — | 32.00% | 23.38% | -64.15% | -540.00% | -408.33% |
| Other Income | 0.09 | 0.27 | 0.31 | 0.01 | 0.17 | 0.08 | 0.00 | 0.01 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.07 | 0.05 | 0.05 |
| Profit before tax | -0.26 | 0.44 | -0.40 | 0.29 | 0.31 | -0.33 | -0.59 | -0.53 |
| Tax % | 0.00% | -61.36% | 0.00% | 0.00% | 9.68% | -3.03% | 0.00% | 0.00% |
| Net Profit | -0.26 | 0.71 | -0.40 | 0.29 | 0.29 | -0.31 | -0.59 | -0.53 |
| EPS in Rs | -0.21 | 0.57 | -0.32 | 0.23 | 0.23 | -0.25 | -0.47 | -0.43 |
| Raw PDF | — | — | — | — | — | — | — | — |
| Category | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 10.91 | 0.00 | 0.00 | 0.10 | 7.17 | 2.42 | 2.31 | 1.52 |
| Sales growth | -56.84% | -100.00% | — | — | +7,070.00% | -66.25% | -4.55% | -29.30% |
| Expenses | 19.97 | 0.00 | 0.56 | 0.39 | 2.33 | 2.53 | 2.83 | 2.71 |
| Operating Profit | -9.06 | 0.00 | -0.56 | -0.29 | 4.84 | -0.11 | -0.52 | -1.19 |
| OPM % | -83.04% | — | — | -290.00% | 67.50% | -4.55% | -22.51% | -78.29% |
| Other Income | 1.11 | -0.12 | 0.64 | 0.53 | 0.15 | 0.56 | 0.58 | 0.26 |
| Interest | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.36 | 0.00 | 0.09 | 0.09 | 0.16 | 0.16 | 0.19 | 0.21 |
| Profit before tax | -8.32 | -0.12 | -0.02 | 0.15 | 4.83 | 0.29 | -0.13 | -1.14 |
| Tax % | 0.12% | -8.33% | 50.00% | 0.00% | 19.46% | -93.10% | 15.38% | — |
| Net Profit | -8.33 | -0.11 | -0.04 | 0.15 | 3.89 | 0.56 | -0.14 | -1.14 |
| EPS in Rs | -6.68 | -0.09 | -0.03 | 0.12 | 3.12 | 0.45 | -0.11 | -0.92 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
| Category | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 |
| Reserves | 47.38 | 48.50 | 48.82 | 48.64 | 54.02 | 54.87 | 54.24 | 54.07 |
| Borrowings | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 1.65 | 1.66 | 0.52 | 0.52 | 1.60 | 0.68 | 0.63 | 0.65 |
| Total Liabilities | 61.56 | 62.63 | 61.81 | 61.63 | 68.09 | 68.02 | 67.34 | 67.19 |
| Fixed Assets | 3.63 | 3.26 | 2.78 | 2.46 | 3.34 | 3.18 | 3.31 | 1.79 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.08 | 0.00 | 0.00 |
| Investments | 52.15 | 54.39 | 53.68 | 51.98 | 54.03 | 55.81 | 55.13 | 57.21 |
| Other Assets | 5.78 | 4.98 | 5.35 | 7.19 | 10.72 | 8.95 | 8.90 | 8.19 |
| Total Assets | 61.56 | 62.63 | 61.81 | 61.63 | 68.09 | 68.02 | 67.34 | 67.19 |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 1.33 | -0.92 | 2.24 | -0.95 | -2.60 | 3.09 | 1.85 | -0.47 |
| Cash from Investing Activity | -1.19 | -0.40 | -2.19 | 1.01 | 1.85 | -3.09 | -1.85 | 0.42 |
| Cash from Financing Activity | -0.05 | -0.06 | -0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Cash Flow | 0.09 | -1.38 | -0.02 | 0.06 | -0.75 | 0.00 | 0.01 | -0.05 |
| Free Cash Flow | 1.00 | -0.92 | 2.28 | -0.65 | -2.45 | 3.13 | 1.78 | -0.72 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | -3,575% | 10% | — | 170% | 897% | 83% | -1,445% | 85% |
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 50.61% | 50.76% | 50.76% | 50.76% | 50.76% | 51.36% | 51.44% | 51.44% |
| DIIs | 0.03% | 0.03% | 0.03% | 0.03% | 0.02% | 0.02% | 0.02% | 0.02% |
| Public | 49.35% | 49.21% | 49.21% | 49.19% | 49.21% | 48.61% | 48.54% | 48.53% |
| No. of Shareholders | 11,176 | 11,033 | 10,851 | 10,692 | 10,493 | 10,349 | 10,209 | 10,369 |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 90.24 | 88.99 | — | — | 8,176.00 | 236.72 | 552.02 | 466.13 |
| Inventory Days | 266.47 | 20.89 | 1,825.00 | — | — | — | — | — |
| Days Payable | 118.09 | 16.56 | 1,095.00 | — | — | — | — | — |
| Cash Conversion Cycle | 238.62 | 93.33 | — | — | 8,176.00 | 236.72 | 552.02 | 466.13 |
| Working Capital Days | 159.25 | 131.81 | — | — | 25,623.00 | 481.07 | 1,297.11 | 1,357.29 |
| ROCE % | 0.77% | -13.56% | 0.00% | -0.85% | -0.62% | 7.34% | -0.13% | -0.91% |
Medi Caps Ltd.
₹27.5Cr.
₹22.0
₹38.8/20.3
Incorporated in 1983, Medi-Caps Ltd is in the business of real estate and pharmaceuticals[1]
Quarterly results
Profit & loss
Shareholding trend
Balance sheet
Cash flows
Key ratios
Frequently asked questions
What is the market cap of MEDI CAPS LTD. (MEDICAPQ)?
The reported market capitalisation for MEDI CAPS LTD. (MEDICAPQ) is ₹27.5Cr. on Fincrux. Figures may update with market data and filings.
What is the current share price of MEDICAPQ?
The current price shown for MEDI CAPS LTD. (MEDICAPQ) on Fincrux is ₹22.0 with a 52-week high/low of ₹38.8/20.3.
What were MEDICAPQ latest quarterly results?
For Sep 2026, MEDI CAPS LTD. (MEDICAPQ) reported sales ₹0.12 Cr and net profit ₹-0.53 Cr (figures in ₹ crore unless noted).
What are MEDICAPQ annual sales and net profit?
For TTM, MEDI CAPS LTD. (MEDICAPQ) shows sales of ₹1.52 Cr and net profit of ₹-1.14 Cr on the Fincrux profit & loss statement.
Who owns MEDI CAPS LTD. (MEDICAPQ)?
Latest shareholding for MEDI CAPS LTD. (MEDICAPQ) on Fincrux: Promoters 51.44% (Sep 2026), DIIs 0.02% (Sep 2026), Public 48.53% (Sep 2026), No. of Shareholders 10,369% (Sep 2026).
Where can I find MEDI CAPS LTD. (MEDICAPQ) financials?
MEDI CAPS LTD. (MEDICAPQ) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.
Does Fincrux show MEDICAPQ balance sheet and cash flow?
Yes. The MEDI CAPS LTD. (MEDICAPQ) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.